Researcher
Michiel THOMEER
- Keywords:Medicine, Biomedical sciences (incl. biochemistry)
- Disciplines:Cancer biology, Cancer diagnosis, Cancer prevention, Cancer therapy
Affiliations
- Cardio & organ systems (Department)
Member
From1 Jan 2020 → Today - Cardio & organ systems (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Oct 2009 → Today - Immunology - Biochemistry (Research group)
Member
From1 Sep 2012 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2009 → 31 Dec 2019
Projects
1 - 4 of 4
- Combining PETCT with a glutamate based blood test improves cancer diagnosis in solitary pulmonary nodules.From1 Oct 2021 → TodayFunding: Nonprofit institution or equivalents
- Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity.From1 Jan 2021 → TodayFunding: BOF - projects
- Towards better therapy for resectable lung cancer: Metabolomics predict therapy responseFrom1 Dec 2017 → 30 Nov 2022Funding: Nonprofit institution or equivalents
- Quantifying tumor heterogeneity in lung cancer: novel insights from non-invasive imaging techniques.From1 Oct 2014 → 30 Apr 2015Funding: BOF - Doctoral projects
Publications
41 - 50 of 66
- Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?(2016)
Authors: Evelyne LOUIS, Peter ADRIAENSENS, Wanda GUEDENS, Karolien VANHOVE, Kurt Vandeurzen, Karen Darquennes, Johan Vansteenkiste, Christophe Dooms, Eric DE JONGE, Michiel THOMEER, et al.
Pages: 178 - 184 - Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma(2016)
Authors: Evelyne LOUIS, Peter ADRIAENSENS, Wanda GUEDENS, Theophile BIGIRUMURAME, Kurt BAETEN, Karolien VANHOVE, Kurt Vandeurzen, Karen Darquennes, Johan Vansteenkiste, Christophe Dooms, et al.
Pages: 516 - 523 - Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)(2016)
Authors: Michael Kreuter, Johan Vansteenkiste, Jürgen Fischer, Wilfried Eberhardt, Heike Zabeck, Jens Kollmeier, Monika Serke, Norbert Frickhofen, Martin Reck, Walburga Engel-Riedel, et al.
Pages: 85 - 93 - 2015, big data in healthcare: for whom the bell tolls?(2015)
Authors: Sven VAN POUCKE, Michiel THOMEER, A HADZIC
- Phenotyping human blood plasma by 1H-NMR: a robust protocol based on metabolite spiking and its evaluation in breast cancer(2015)
Authors: Evelyne LOUIS, Liene BERVOETS, Gunter REEKMANS, Eric DE JONGE, Liesbet MESOTTEN, Michiel THOMEER, Peter ADRIAENSENS
Pages: 225 - 236 - Prognostic value of quantitative FDG PET/CT uptake metrics in NSCLC(2015)
Authors: Karolien VANHOVE, Mesotten Liesbet, Evelyne LOUIS, Michiel THOMEER, Peter ADRIAENSENS, Ronald Boellaard
- Prognostic value of quantitative FDG PET/CT uptake metrics in non-small cell lung cancer(2015)
Authors: Karolien VANHOVE, Liesbet MESOTTEN, Evelyne LOUIS, Michiel THOMEER, Peter ADRIAENSENS, Ronald Boellaard
Pages: 177 - 177 - Metabolomics a novel biomarker in lung cancer(2015)
Authors: Kirsten STINKENS, Karolien VANHOVE, Michiel THOMEER
Pages: e46 - e46 - Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer(2015)
Authors: Jean-Louis Pujol, Johan F. Vansteenkiste, Tommaso Martino De Pas, Djordje Atanackovic, Martin Reck, Michiel THOMEER, Jean-Yves Douillard, Gianpiero Fasola, Vanessa Potter, Paul Taylor, et al.
Pages: 1458 - 1467 - Influence of preanalytical sampling conditions on the 1 H NMR metabolic profile of human blood plasma and introduction of the Standard PREanalytical Code used in biobanking(2015)
Authors: Liene BERVOETS, Evelyne LOUIS, Gunter REEKMANS, Liesbet MESOTTEN, Michiel THOMEER, Peter ADRIAENSENS, Loes LINSEN
Pages: 1197 - 1207